Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Paresthesia-Free Fast-Acting Subperception (FAST) Study

NCT: NCT04618471 · ACTIVE_NOT_RECRUITING

NCT IDNCT04618471
StatusACTIVE_NOT_RECRUITING
Start Date2021-02-10
Completion2029-03

Brief Summary

Study to evaluate the effectiveness of FAST-SCS (fast-acting paresthesia-free therapy) and additional SCS therapy options in patients with chronic pain using Boston Scientific WaveWriter SCS Systems.

Frequently Asked Questions

What is Paresthesia-Free Fast-Acting Subperception (FAST) Study?

Paresthesia-Free Fast-Acting Subperception (FAST) Study is a clinical trial registered under NCT04618471. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04618471?

The current status of NCT04618471 (Paresthesia-Free Fast-Acting Subperception (FAST) Study) is: ACTIVE_NOT_RECRUITING.

When did Paresthesia-Free Fast-Acting Subperception (FAST) Study start?

Paresthesia-Free Fast-Acting Subperception (FAST) Study started on 2021-02-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑